Close Menu

This story has been corrected to reflect that the PanCan initiative cited is the Know Your Tumor initiative, not the Know Your Cancer intiative.

NEW YORK (GenomeWeb) – A consortium of researchers affiliated with the Pancreatic Cancer Action Network's (PanCAN) Know Your Tumor Initiative have found that molecularly tailored treatments could improve patient outcomes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.